| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/05/2011 | US20110105464 Phosphoinositide 3-kinase inhibitor compounds and methods of use |
| 05/05/2011 | US20110105463 6-substituted phenoxychroman carboxylic acid derivatives |
| 05/05/2011 | US20110105462 Modulators of dopamine neurotransmission |
| 05/05/2011 | US20110105461 Modulators of dopamine neurotransmission |
| 05/05/2011 | US20110105460 Triazole derivative or salt thereof |
| 05/05/2011 | US20110105459 Azetidines and cyclobutanes as histamine h3 receptor antagonists |
| 05/05/2011 | US20110105458 Fatty acid inhibitors |
| 05/05/2011 | US20110105457 Heterocyclic compound having inhibitory activity on pi3k |
| 05/05/2011 | US20110105456 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 05/05/2011 | US20110105455 Phenoxy-substituted pyrimidines as opioid receptor modulators |
| 05/05/2011 | US20110105454 Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses |
| 05/05/2011 | US20110105453 Superoxide Dismutase Mimics For The Treatment Of Optic Nerve And Retinal Damage |
| 05/05/2011 | US20110105452 Oxidant Scavengers for Treatment of Diabetes or Use in Transplantation or Induction of Immune Tolerance |
| 05/05/2011 | US20110105451 Screening of a Novel Hepatic Syndrome and its Uses |
| 05/05/2011 | US20110105450 Ophthalmic formulations of fluticasone and methods of use |
| 05/05/2011 | US20110105449 Dry powder formulations comprising ascorbic acid derivates |
| 05/05/2011 | US20110105448 Stable Topical Formulation Comprising Voriconazole |
| 05/05/2011 | US20110105447 Novel modulators of calcium release-activated calcium channel |
| 05/05/2011 | US20110105446 Sustained Release Enhanced Lipolytic Formulation for Regional Adipose Tissue Treatment |
| 05/05/2011 | US20110105445 Androgen receptor inactivation contributes to antitumor efficacy of cyp17 inhibitors in prostate cancer |
| 05/05/2011 | US20110105444 Once-a-week administration of 25-hydroxy vitamin d3 to sustain elevated steady-state pharmacokinetic blood concentration |
| 05/05/2011 | US20110105443 Salts of memantine and cox-inhibitors and their crystal form in the treatment of pain |
| 05/05/2011 | US20110105442 Means and methods for controlling commensales |
| 05/05/2011 | US20110105441 Stable Orally Disintegrating Tablets Having Low Superdisintegrant |
| 05/05/2011 | US20110105440 HEXAHYDROCYCLOPENTYL[f]INDAZOLE SULFONAMIDES AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS |
| 05/05/2011 | US20110105438 Oligomer-Foscarnet Conjugates |
| 05/05/2011 | US20110105437 Mitochondrially Delivered Anti-Cancer Compounds |
| 05/05/2011 | US20110105436 Heteroaryl compounds, compositions, and methods of use in cancer treatment |
| 05/05/2011 | US20110105435 Therapy option for recoloration of hair via bisphosphonates by physiological repigmentation with age-related and/or premature "grayed" patients |
| 05/05/2011 | US20110105434 2-amino purine derivatives and their use as anti-herpetic agents |
| 05/05/2011 | US20110105433 Lecithin and lc-pufa |
| 05/05/2011 | US20110105432 Aminocarboxylic acid derivative and medicinal use thereof |
| 05/05/2011 | US20110105431 Boronic Acid Aryl Analogs |
| 05/05/2011 | US20110105430 Pyrrolo [2,3-c] pyridine derivatives as p38 kinease inhibiting agents |
| 05/05/2011 | US20110105428 Hydrolysis resistant organomodified silylated ionic surfactants |
| 05/05/2011 | US20110105427 Deazapurines and uses thereof |
| 05/05/2011 | US20110105426 Compositions and methods for treating corneal inflammation |
| 05/05/2011 | US20110105425 Use of adenosine aspartate for the preparation of pharmaceutical products for the treatment of liver cancer |
| 05/05/2011 | US20110105424 Glucopyranoside compound |
| 05/05/2011 | US20110105423 Compounds that modulate negative-sense, single-stranded rna virus replication and uses thereof |
| 05/05/2011 | US20110105422 Use of g-rich oligonucleotides for treating neoplastic diseases |
| 05/05/2011 | US20110105421 Ellagitannins as inhibitors of bacterial quorum sensing |
| 05/05/2011 | US20110105420 Aminosugar compound and process for production thereof |
| 05/05/2011 | US20110105419 Pharmacological adjuvants based on coordination compounds of d-metals |
| 05/05/2011 | US20110105418 Process for preparing fondaparinux sodium and intermediates useful in the synthesis thereof |
| 05/05/2011 | US20110105417 Drug Conjugates |
| 05/05/2011 | US20110105413 Polymeric systems containing intracellular releasable disulfide linker for the delivery of oligonucleotides |
| 05/05/2011 | US20110105411 Disease-Associated Proteins |
| 05/05/2011 | US20110105388 Novel possibility of controlling giardiosis |
| 05/05/2011 | US20110105387 Method of treatment with rapamycin |
| 05/05/2011 | US20110105381 Prodrugs of Peripheral Phenolic Opioid Antagonists |
| 05/05/2011 | US20110105380 Protection of Nano-Scale Particles from Immune Cell Uptake |
| 05/05/2011 | US20110105321 Pesticidal Mixtures Comprising Cyanosulfoximine Compounds |
| 05/05/2011 | US20110104315 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 05/05/2011 | US20110104308 Treatment For Diseases Relying On Discovery That Thioredoxin Mediates Nitric Oxide |
| 05/05/2011 | US20110104306 Novel compositions and methods for the identification, assessment, prevention and therapy of human cancers |
| 05/05/2011 | US20110104305 Compounds and methods for thiol-containing compound efflux and cancer treatment |
| 05/05/2011 | US20110104304 O-Methylated Rapamycin Derivatives For Alleviation And Inhibition Of Lymphoproliferative Disorders |
| 05/05/2011 | US20110104301 Methods of reducing pain and inflammation |
| 05/05/2011 | US20110104295 Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate fucans |
| 05/05/2011 | US20110104294 Magnetic nanocomposite for inhibiting/treating cancer and method for fabricating the same |
| 05/05/2011 | US20110104291 Formulation of Fine Particles Using Liquefied or Dense Gases |
| 05/05/2011 | US20110104289 Method and pharmaceutical composition for obtaining the plasmatic progesterone levels required for different therapeutic indications |
| 05/05/2011 | US20110104287 Fenoldopam formulations and pro-drug derivatives |
| 05/05/2011 | US20110104285 Process for the manufacture of a pharmaceutical product |
| 05/05/2011 | US20110104282 New Therapy of Treatment of the Irritable Bowel Syndrome |
| 05/05/2011 | US20110104281 Method for treating pain using a substituted 2-aminotetralin compound |
| 05/05/2011 | US20110104279 Healing powder and method of use thereof |
| 05/05/2011 | US20110104277 Oxygen barrier film coatings for pharmaceutical dosage forms |
| 05/05/2011 | US20110104276 Pharmaceutical composition containing as an active ingredient 5-methyl-1-phenyl-2-(1h)-pyridone |
| 05/05/2011 | US20110104275 Methods and kits for treating cluster headache disorders |
| 05/05/2011 | US20110104274 Novel composition and uses thereof, in particular cosmetic uses, for treating skin dehydration |
| 05/05/2011 | US20110104273 Gastric retentive pharmaceutical compositions for immediate and extended release of phenylephrine |
| 05/05/2011 | US20110104272 Gastric retentive extended-release dosage forms comprising combinations of acetaminophen and phenylephrine |
| 05/05/2011 | US20110104271 Microcrystalline Cellulose and Calcium Phosphate Compositions Useful as Pharmaceutical Excipients |
| 05/05/2011 | US20110104270 Process for production of spherical microparticles comprising tamsulosin hydrochloride |
| 05/05/2011 | US20110104269 Compositions for the oral delivery of corticosteroids |
| 05/05/2011 | US20110104268 Galenic applications of self-emulsifying mixtures of lipidic excipients |
| 05/05/2011 | US20110104267 Pharmaceutical compositions of antiretrovirals |
| 05/05/2011 | US20110104265 Compositions and methods of targeted nanoformulations in the management of osteoporosis |
| 05/05/2011 | US20110104264 Gastric acid secretion inhibiting composition |
| 05/05/2011 | US20110104262 Topical Combinations Comprising an Antimycotic Agent and an Antiviral Agent |
| 05/05/2011 | US20110104258 Technique for drug and gene delivery to the cell cytosol |
| 05/05/2011 | US20110104257 Polymorphisms predictive of platinum-coordinating compound-induced ototoxicity |
| 05/05/2011 | US20110104255 Therapeutic agent for fibroid lung |
| 05/05/2011 | US20110104254 Medicament for treatment of tumors wherein hedgehog/smoothened signaling is employed for inhibition of apoptosis of the tumor cells |
| 05/05/2011 | US20110104253 Agent for intra-articular injection |
| 05/05/2011 | US20110104252 Anti-apoptotic gene scc-s2 and diagnostic and therapeutic uses thereof |
| 05/05/2011 | US20110104251 Cosmetic Composition And Method For Retarding Hair Growth |
| 05/05/2011 | US20110104249 Oncotherapeutic Application of Inhibitors of High-Affinity Glucose Transporters |
| 05/05/2011 | US20110104248 Liposomes and immunopotentiating compositions containing the same |
| 05/05/2011 | US20110104247 Composition for stabilizing beta-blocker and transdermally absorbable preparation comprising the same |
| 05/05/2011 | US20110104245 Pressure-sensitive adhesives based on ethylene-vinyl acetate copolymers and adhesive resins, for medical application purposes |
| 05/05/2011 | US20110104244 Transdermal therapeutic system provided with improved long-term carrying comfort |
| 05/05/2011 | US20110104241 Percutaneous absorption enhancer and transdermal preparation using the same |
| 05/05/2011 | US20110104235 Compositions and methods for treating conditions of the nail unit |
| 05/05/2011 | US20110104234 Biodegradable Modified Carpolactone Polymers for Fabrication and Coating Medical Devices |
| 05/05/2011 | US20110104233 Flowable composition that sets to a substantially non-flowable state |
| 05/05/2011 | US20110104232 Sustained Release Systems of Ascorbic Acid Phosphate |
| 05/05/2011 | US20110104228 Self-eliminating coatings |